Citations 745

Age, Sex, andAPOEε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span

JAMA Neurology | March 16, 2015 | Volume: 72 | Issue: 5 | Pages: 511

10.1001/jamaneurol.2014.4821 | PMID 25775353

NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging

Neurology Clinical Practice | December 8, 2014 | Volume: 4 | Issue: 6 | Pages: 470-473

10.1212/cpj.0000000000000074 | PMID 25566417

Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging

Alzheimer's & Dementia | November 15, 2014 | Volume: 10 | Issue: 6 | Pages: 779-789

10.1016/j.jalz.2014.09.001 | PMID 25458308

AbstractBackgroundInexpensive, non‐invasive tools for assessing Alzheimer‐type pathophysiologies are needed. Computerized cognitive assessments are prime candidates.MethodsCognitively normal participants, aged 51–71, with magnetic resonance imaging, fluorodeoxyglucose‐positron emission tomography (FDG‐PET), amyloid PET, CogState computerized cognitive assessment, and standard neuropsychological tests were included. We first examined the association between the CogState battery and neuroimaging measures. We then compared that association to the one between standard neuropsychological z‐scores and neuroimaging.ResultsSlower reaction times for CogState Identification and One Back, and lower memory and attention z‐scores, were associated (P < .05) with FDG‐PET hypometabolism. Slower time on the Groton Maze Learning Task and worse One Card Learning accuracy were associated (P < .05) with smaller hippocampal volumes. There were no associations with amyloid PET. Associations of CogState and neuropsychological Z‐scores with neuroimaging were small and of a similar magnitude.ConclusionsCogState subtests were cross‐sectionally comparable to standard neuropsychological tests in their relatively weak associations with neurodegeneration imaging markers.
White Matter Integrity Determined With Diffusion Tensor Imaging in Older Adults Without Dementia

JAMA Neurology | October 27, 2014 | Volume: 71 | Issue: 12 | Pages: 1547

10.1001/jamaneurol.2014.1482 | PMID 25347157

IC‐02‐06: LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOLOGICAL MEASURES IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_1 | Pages: No page available

10.1016/j.jalz.2014.04.029

IC‐P‐062: DATSCAN FINDINGS IN PATIENTS WITH REM SLEEP BEHAVIOR DISORDER AND/OR COGNITIVE IMPAIRMENT

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2014.05.067

P1‐264: LONGITUDINAL CHANGES IN BRAIN MRI AND NEUROPSYCHOMETRICS IN ASYMPTOMATIC AND SYMPTOMATIC FAMILIAL FRONTOTEMPORAL LOBAR DEGENERATION WITH MUTATIONS IN MAPT

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_10 | Pages: No page available

10.1016/j.jalz.2014.05.504

IC‐P‐029: ENHANCED BRAIN UPTAKE OF C11‐PIB IN MOUSE MODEL OF ALZHEIMER'S DISEASE VIA A SYNTHETIC PEPTIDE CARRIER

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_6 | Pages: No page available

10.1016/j.jalz.2014.05.033

O1‐12‐03: THAL AMYLOID PHASE: CLINICOPATHOLOGIC AND PIB‐PET IMPLICATIONS OF AD PATHOPHYSIOLOGY

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_2 | Pages: No page available

10.1016/j.jalz.2014.04.124

O5‐01‐04: CLINICAL AND NEUROIMAGING BIOMARKERS OF ALZHEIMER'S DISEASE PRESENTING WITH PROGRESSIVE APHASIA

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2014.04.479